The French government introduced on Wednesday the choice to revoke the Might 11 decree that licensed the administration of hydroxychloroquine to sufferers contaminated with Covid-19. This malaria drug has been used to deal with essentially the most critical instances within the nation since March, however it’s now banned.
Belgium and Italy are additionally putting new boundaries on the usage of hydroxychloroquine. Belgian well being authorities take into account the drug to be discouraged and urges it not for use in scientific trials.
In the identical vein, Italian well being authorities right this moment thought-about that there’s “little proof” to help the usage of hydroxychloroquine in sufferers with Covid-19, so the drug must be abolished from scientific trials.
In keeping with the Italian Medicines Company (AIFA), the newest scientific proof signifies “an elevated danger of opposed reactions with little or no profit”.
In France, the Superior Council for Public Well being and the Nationwide Company for the Security of Medicines and Well being Merchandise issued a unfavorable opinion on the prescription of this medication within the remedy of Covid-19.
The choice of the three international locations comes days after the publication of a research within the journal The Lancet, the primary research on the consequences of hydroxychloroquine in customers with Covid-19, which concludes that the drug will increase the danger of loss of life. Initially of the week, the World Well being Group introduced the short-term suspension of scientific trials with the drug.
For the reason that starting of the pandemic, hydroxychloroquine has been utilized in a number of international locations within the remedy of the brand new coronavirus with out an investigation to show its effectiveness.
Extra not too long ago, the drug has been within the limelight, particularly since Donald Trump admitted he was taking hydroxychloroquine every single day to stop an infection with the brand new coronavirus.